Beyond the influence of new therapies on drug pricing trends, Cowen’s report also accounted for the effects of legislation ...

Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...

The cost of prescription drugs is set to climb in 2025 and beyond, according to TD Cowen’s 30th Annual Drug Pricing survey.

AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...

Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...